Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 30 entities : Bristol-myers squibb company save search
Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
Published: 2021-07-30 (Crawled : 23:00) - prnewswire.com
GSK | $39.605 0.85% 790K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.81 1.34% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.185 0.19% 430K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.58 0.58% 2.6M
|
Health Technology
| Email alert
Add to watchlist
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
Published: 2021-07-30 (Crawled : 17:00) - biospace.com/
VRPX | $3.86 -4.46% 5.1K
|
|
| O: 2.0%
H: 0.0%
C: 0.0%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy
Published: 2021-07-30 (Crawled : 12:00) - biospace.com/
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
disease treatment europe therapy cancer iot approval nivolumab
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
CHRO | $1.53 24.9% 100K
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.